Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GEHC
stocks logo

GEHC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
5.60B
+5.33%
1.400
-3.43%
5.01B
+4.8%
1.005
-0.49%
5.23B
+4.39%
1.161
+9.5%
Estimates Revision
The market is revising Upward the revenue expectations for GE HealthCare Technologies Inc. (GEHC) for FY2025, with the revenue forecasts being adjusted by 0.49% over the past three months. During the same period, the stock price has changed by 8.97%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.49%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.95%
In Past 3 Month
Stock Price
Go Up
up Image
+8.97%
In Past 3 Month
Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 88.18 USD with a low forecast of 80.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 88.18 USD with a low forecast of 80.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 82.520
sliders
Low
80.00
Averages
88.18
High
95.00
Current: 82.520
sliders
Low
80.00
Averages
88.18
High
95.00
Wells Fargo
Larry Biegelsen
Overweight
maintain
$89 -> $87
2025-10-30
Reason
Wells Fargo
Larry Biegelsen
Price Target
$89 -> $87
2025-10-30
maintain
Overweight
Reason
Wells Fargo analyst Larry Biegelsen lowered the firm's price target on GE HealthCare to $87 from $89 and keeps an Overweight rating on the shares. The firm notes the company delivered a beat on the top line and EPS of $1.07 was ahead of both consensus and Wells Fargo's estimates. EBIT margins were down 150bps year-over-year, but above the firm's estimates. GE HealthCa raised the lower end of 2025 EPS guidance, but Flyrcado to be less than $30M in 2025 sales.
Morgan Stanley
Patrick Wood
Equal Weight
maintain
$74 -> $80
2025-10-29
Reason
Morgan Stanley
Patrick Wood
Price Target
$74 -> $80
2025-10-29
maintain
Equal Weight
Reason
Morgan Stanley analyst Patrick Wood raised the firm's price target on GE HealthCare to $80 from $74 and keeps an Equal Weight rating on the shares. The firm said it updated its model for Q3 earnings, which were slightly above expectations. Demand is looking solid for GE HealthCare, with solid order backlog and peer results, and the firm's hospital CapEx survey suggests a healthy environment, the analyst tells investors in a research note. The analyst added that it equally believes mid-term margin targets are sensible and sees upside risk long-term from photon counting.
BTIG
Buy
downgrade
$89 -> $87
2025-10-29
Reason
BTIG
Price Target
$89 -> $87
2025-10-29
downgrade
Buy
Reason
BTIG lowered the firm's price target on GE HealthCare to $87 from $89 and keeps a Buy rating on the shares following Q3 results. The firm, which thinks focus shifts to FY26, views the Street forecast for about 4% organic revenue growth with adjusted EPS of $4.93 as "achievable" given GE HealthCare's performance history, the analyst tells investors.
BTIG
Buy
maintain
$82 -> $87
2025-07-14
Reason
BTIG
Price Target
$82 -> $87
2025-07-14
maintain
Buy
Reason
BTIG raised the firm's price target on GE HealthCare to $87 from $82 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results in MedTech. Healthcare was a laggard in Q2 relative to the S&P, and early into Q3, MedTech is underperforming as fears of Medicaid cuts and hospital closures weigh on the sector following recent legislation, the analyst tells investors in a research note. The fears are likely overblown, though the earnings season is likely to offer a mixed picture as sentiment is extremely binary right now, with some companies pushing extreme valuations and others "left for dead", BTIG notes. The firm adds however that on one hand, inflation is calm, markets are at highs, and Fx has turned demonstrably favorable.
Citi
Buy
maintain
$86 -> $89
2025-07-09
Reason
Citi
Price Target
$86 -> $89
2025-07-09
maintain
Buy
Reason
Citi raised the firm's price target on GE HealthCare to $89 from $86 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Goldman Sachs
David Roman
Hold
to
Strong Buy
Upgrades
$85 → $100
2025-03-11
Reason
Goldman Sachs
David Roman
Price Target
$85 → $100
2025-03-11
Upgrades
Hold
to
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for GE Healthcare Technologies Inc (GEHC.O) is 17.15, compared to its 5-year average forward P/E of 18.20. For a more detailed relative valuation and DCF analysis to assess GE Healthcare Technologies Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
18.20
Current PE
17.15
Overvalued PE
20.02
Undervalued PE
16.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
11.44
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
13.02
Undervalued EV/EBITDA
9.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.74
Current PS
0.00
Overvalued PS
2.00
Undervalued PS
1.48
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 129.92% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

GEHC News & Events

Events Timeline

(ET)
2025-12-03
13:10:00
GE HealthCare and Mayo Clinic Launch GEMINI-RT Initiative
select
2025-12-03
09:10:00
University of Rochester Medical Center and GE HealthCare Form Seven-Year Care Alliance
select
2025-12-01 (ET)
2025-12-01
03:52:00
GE HealthCare Files 510(k) for Next-Gen SIGNA MRI Technology
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.5
12-04Newsfilter
GE HealthCare and Mayo Clinic Launch GEMINI-RT for Personalized Radiation Therapy
  • Strategic Collaboration: GE HealthCare and Mayo Clinic have launched the GEMINI-RT initiative aimed at enhancing personalized radiation therapy through the integration of imaging, AI, and patient monitoring, which is expected to significantly improve clinical outcomes and reduce clinician burnout.
  • Innovation Focus: The initiative concentrates on four key areas: automation, predictive oncology, multi-modal therapies, and outpatient monitoring, leveraging Mayo Clinic's clinical expertise alongside GE HealthCare's technological innovations to drive rapid advancements in radiation oncology.
  • Market Demand: With the global cancer incidence rising to 19.3 million new cases in 2022, and radiation therapy being a cornerstone treatment for over 2 million U.S. patients annually, GEMINI-RT aims to make personalized radiation therapy more accessible.
  • Research Foundation: GEMINI-RT activities will be based at Mayo Clinic's Rochester, Minnesota campus, combining the strengths of both organizations in clinical practice, research, and product development to advance cutting-edge radiation therapy technologies.
[object Object]
Preview
5.0
12-03NASDAQ.COM
GEHC Launches Allia Moveo to Enhance Mobility in Interventional Care

  • Introduction of Allia Moveo: GE HealthCare has launched Allia Moveo, a next-generation interventional imaging platform designed to enhance mobility, access, and workflow in medical procedures, featuring a compact, cable-free C-arm for improved patient comfort and high-quality imaging.

  • Technological Advancements: The platform integrates AI-driven workflow tools and multi-modality capabilities, aiming to streamline clinician operations and support higher case volumes in minimally invasive procedures, thereby enhancing GEHC's competitiveness in the market.

  • Market Performance: Following the announcement, GEHC's shares remained stable, with a year-to-date gain of 1.3%, contrasting with a 4.9% decline in the industry, while the S&P 500 has increased by 18.8%.

  • Future Prospects: Allia Moveo is expected to strengthen GEHC's position in interventional imaging, drive adoption across diverse care settings, and generate recurring revenue through service and software integrations, with FDA clearance pending.

[object Object]
Preview
3.5
12-02Newsfilter
GE HealthCare Integrates NVIDIA Tech in New Imaging Solutions at RSNA 2025
  • Technology Integration: At RSNA 2025, GE HealthCare showcased innovations resulting from its collaboration with NVIDIA, launching several new imaging solutions aimed at enhancing diagnostic efficiency and patient comfort through advanced AI technologies.
  • Data Processing Capability: The newly introduced Photonova Spectra™ CT system leverages NVIDIA technology to process data at speeds up to 50 times faster than standard CT systems, significantly improving image clarity and diagnostic confidence, addressing the urgent need for efficient imaging in healthcare.
  • Automation in Imaging: GE HealthCare and NVIDIA are jointly exploring autonomous X-ray and ultrasound imaging solutions, aiming to streamline workflows through AI technology, which could enhance diagnostic turnaround times and expand access to care, particularly in underserved areas.
  • Market Outlook: This collaboration not only highlights GE HealthCare's innovative capabilities in imaging technology but also underscores its commitment to driving digital transformation in the healthcare sector by integrating NVIDIA's computing platforms to enhance overall service quality.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is GE Healthcare Technologies Inc (GEHC) stock price today?

The current price of GEHC is 82.52 USD — it has decreased -1.28 % in the last trading day.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s business?

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

arrow icon

What is the price predicton of GEHC Stock?

Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 88.18 USD with a low forecast of 80.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s revenue for the last quarter?

GE Healthcare Technologies Inc revenue for the last quarter amounts to 5.14B USD, increased 5.76 % YoY.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s earnings per share (EPS) for the last quarter?

GE Healthcare Technologies Inc. EPS for the last quarter amounts to 0.98 USD, decreased -3.92 % YoY.

arrow icon

What changes have occurred in the market's expectations for GE Healthcare Technologies Inc (GEHC)'s fundamentals?

The market is revising Upward the revenue expectations for GE HealthCare Technologies Inc. (GEHC) for FY2025, with the revenue forecasts being adjusted by 0.49% over the past three months. During the same period, the stock price has changed by 8.97%.
arrow icon

How many employees does GE Healthcare Technologies Inc (GEHC). have?

GE Healthcare Technologies Inc (GEHC) has 53000 emplpoyees as of December 05 2025.

arrow icon

What is GE Healthcare Technologies Inc (GEHC) market cap?

Today GEHC has the market capitalization of 37.59B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free